Analysts Set Sanofi (NASDAQ:SNY) Target Price at $55.00

Shares of Sanofi (NASDAQ:SNY) have been given an average recommendation of “Hold” by the six analysts that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $55.00.

Several research firms recently issued reports on SNY. StockNews.com downgraded Sanofi from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, February 27th. TheStreet downgraded shares of Sanofi from a “b” rating to a “c” rating in a research note on Friday, February 9th. Finally, Morgan Stanley began coverage on shares of Sanofi in a report on Tuesday, January 23rd. They issued an “equal weight” rating and a $55.00 price objective for the company.

Hedge Funds Weigh In On Sanofi

Several hedge funds and other institutional investors have recently made changes to their positions in SNY. SRS Capital Advisors Inc. increased its stake in Sanofi by 289.1% in the first quarter. SRS Capital Advisors Inc. now owns 463 shares of the company’s stock valued at $25,000 after acquiring an additional 344 shares during the last quarter. Householder Group Estate & Retirement Specialist LLC acquired a new position in shares of Sanofi during the 3rd quarter worth $26,000. Indiana Trust & Investment Management CO bought a new stake in shares of Sanofi during the 3rd quarter worth $27,000. Fairfield Bush & CO. acquired a new stake in Sanofi in the first quarter valued at about $26,000. Finally, Rise Advisors LLC grew its position in Sanofi by 98.4% in the fourth quarter. Rise Advisors LLC now owns 506 shares of the company’s stock valued at $25,000 after acquiring an additional 251 shares during the last quarter. 10.04% of the stock is currently owned by institutional investors and hedge funds.

Sanofi Stock Down 1.6 %

SNY stock opened at $45.39 on Tuesday. The business’s 50 day simple moving average is $47.52 and its 200 day simple moving average is $48.67. Sanofi has a 1-year low of $42.63 and a 1-year high of $57.82. The firm has a market capitalization of $114.82 billion, a PE ratio of 19.23, a PEG ratio of 1.71 and a beta of 0.61. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.19.

Sanofi (NASDAQ:SNY) last issued its quarterly earnings data on Thursday, February 1st. The company reported $0.89 earnings per share for the quarter, missing the consensus estimate of $0.94 by ($0.05). Sanofi had a net margin of 12.56% and a return on equity of 27.47%. The company had revenue of $11.76 billion during the quarter, compared to the consensus estimate of $13.02 billion. As a group, research analysts anticipate that Sanofi will post 4.16 EPS for the current year.

Sanofi Increases Dividend

The business also recently declared an annual dividend, which will be paid on Thursday, June 6th. Investors of record on Friday, May 10th will be paid a $1.478 dividend. This represents a yield of 2.98%. The ex-dividend date of this dividend is Thursday, May 9th. This is an increase from Sanofi’s previous annual dividend of $1.38. Sanofi’s payout ratio is 58.47%.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.